Skip to main content

Social Disadvantage Tied to Worse Lung Cancer Outcomes

Medically reviewed by Drugs.com.

By Lori Solomon HealthDay Reporter

THURSDAY, Sept. 28, 2023 -- Social disadvantage is associated with a lower likelihood of achieving textbook oncological outcome and worse survival in patients with non-small cell lung cancer (NSCLC), according to a study published online Sept. 19 in JTCVS Open.

Ahmed Alnajar, M.D., M.S.P.H., from the University of Miami, and colleagues examined whether social determinants of health can affect both achievement of textbook oncological outcome and overall survival (OS) in patients with surgically resected NSCLC with pathological nodal disease. The analysis included 11,274 patients with NSCLC receiving lobectomy resection, of which 48 percent had textbook oncological outcome.

The researchers found that 15 percent of patients were considered disadvantaged (two or more social determinants of health not met), which was associated with a lower likelihood of achieving textbook oncological outcome (adjusted odds ratio, 0.85) compared with non-socially disadvantaged patients. Further, patients achieving textbook oncological outcome had lower overall mortality (adjusted hazard ratio, 0.78) than patients not achieving textbook oncological outcome. Social disadvantage remained an independently significant risk factor with OS versus not being socially disadvantaged (adjusted hazard ratio, 1.24). The impact of social disadvantage on OS was significant, regardless of textbook oncological outcome status.

"Addressing social determinants of health is important to optimize care and long-term survival of this patient population," the authors write.

Abstract/Full Text (subscription or payment may be required)

Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.

© 2024 HealthDay. All rights reserved.

Read this next

Sociodemographics Tied to Rehab Use During Critical Illness Hospitalization

FRIDAY, May 10, 2024 -- For older adults hospitalized with a stay in the intensive care unit (ICU), social determinants of health (SDOH) are associated with use of skilled...

Breakthrough Gene Therapy Enables Infant Born Deaf to Hear

FRIDAY, May 10, 2024 -- Significant hearing improvements have been achieved in an infant with profound hearing loss due to a biallelic otoferlin gene (OTOF) mutation, according to...

Implantable Continuous Flow Device Feasible for Small Children With Severe Systolic Heart Failure

FRIDAY, May 10, 2024 -- The Jarvik 2015 left ventricular assist device (LVAD) seems promising as an implantable continuous flow device for small children with severe systolic...

More news resources

Subscribe to our newsletter

Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.